Global EPA and DHA Market, By Type (Eicosapentaenoic Acid, Docosahexaenoic Acid), Concentration Type (High Concentrated, Medium Concentrated, Low Concentrated), Form (Triglycerides, Ethyl Esters), Source (Anchovy/Sardine Oils, High Concentrates, Medium Concentrates, Low Concentrates, Algae Oils, Tuna Oils, Cod Liver Oils, Salmon Oils, Krill Oils, Mehaden Oils), Application (Infant Formulae, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals), Country (U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global EPA and DHA Market
The EPA and DHA market is expected to gain market growth in the forecast period of 2021 to 2028. Data bridge market research analyses that the market is growing with the CAGR of 8.95% in the forecast period of 2021 to 2028. The emergence of clean label product is escalating the growth of EPA and DHA market.
Ready to eat food refer to plant and animal derived food which is initially washed, then cooked. The food product is frozen and processed to be consumed after heating directly. The process is known to save energy and time of the customers. Nowadays, people prefer to eat nutritional small quantity of ready to eat food over traditional large meals because of busy work life.
The increase in demand for the DHA product and its incorporation in infant formulae and nutritional products promoting children's health as are known to be an essential building block for the growth and maturation of an infant's brain and retina acts as the major factor driving the growth of EPA and DHA market. The extensive use of the products obtained from fish and algae oils in fortified foods and dietary supplements and the utilization of the components in the treatment for chronic diseases such as coronary artery disease (CAD), Type 2 diabetes, attention deficit-hyperactivity disorder (ADHD) and dementia accelerate the EPA and DHA market growth. The integration of DHA in geriatric nutrition products, owning to their healthy aging-related benefits, rising penetration of omega 3 in the active pharmaceutical ingredient (API) market and favorable regulations and policies encouraging the use of formulations in in infant nutrition influence the EPA and DHA market. Additionally, the growth in population and geriatric population globally, increasing prevalence of chronic diseases, rise in awareness regarding diseases and treatment among people and surge in disposable income positively affect the EPA and DHA market. Furthermore, research and development activities for obtaining alternative sources and increasing demand for plant-based products extends profitable opportunities to the EPA and DHA market players in the forecast period of 2021 to 2028.
On the other hand, the fluctuation in the prices and high cost associated with the research and development activities are factors expected to obstruct the EPA and DHA market growth. The rise in concerns regarding the mild side effects of EPA and DHA supplements and lack of clarity among consumers about daily recommended intake are projected to challenge the EPA and DHA market in the forecast period of 2021-2028.
This EPA and DHA market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on EPA and DHA market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
EPA and DHA Market Scope and Market Size
The EPA and DHA market is segmented on the basis of concentration type, type, form, source and application. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target markets.
- On the basis of type, the EPA and DHA market is segmented into eicosapentaenoic acid and docosahexaenoic acid.
- On the basis of concentration type, the EPA and DHA market is segmented into high concentrated, medium concentrated and low concentrated.
- On the basis of form, the EPA and DHA market is segmented into triglycerides and ethyl esters.
- On the basis of source, the EPA and DHA market is segmented into anchovy/sardine oils, high concentrates, medium concentrates, low concentrates, algae oils, tuna oils, cod liver oils, salmon oils, krill oils, mehaden oils.
- On the basis of application, the EPA and DHA market is segmented into infant formulae, dietary supplements, fortified food and beverages and pharmaceuticals.
Global EPA and DHA Market Country Level Analysis
The EPA and DHA market is analyzed and market size, volume information is provided by country, concentration type, type, form, source and application as referenced above.
The countries covered in the global EPA and DHA market report are the U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the EPA and DHA market because of the advancements in products and technologies, increasing investments by key players, customizations of EPA and DHA applications in pharmaceutical and dietary supplements and consumer preference towards the consumption of supplements instead of functional food in the region. Europe is expected to witness the significant CAGR during the forecast period of 2021-2028 because of the high consumption of product, especially in the form of dietary supplements and rise in geriatric population in the region.
The country section of the EPA and DHA market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and EPA and DHA Market Share Analysis
The EPA and DHA market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to EPA and DHA market.
The major players covered in the EPA and DHA market report are DSM, ADM, Cargill, Incorporated, BASF SE, Epax, Lonza, Orkla, Corbion, KD Pharma Group SA, GC Rieber, Guangdong Runke Bioengineering Co. Ltd., Nordic Naturals, GOLDEN OMEGA, Biosearch life, Pharma Marine AS, Polaris Inc., Sinomega Biotech Engineering Co., Ltd, Huatai Biopharm Resource Co.,Ltd., KinOmega Biopharm Inc, AlgiSys among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-